AACG (AACG) Stock Price & Analysis
AACG (AACG) fell 0.05% to USD 0.89 as of July 25, 2026 at 15:00 UTC, according to Nexqual real-time market data.
AACG last closed at USD 0.89; the session ranged USD 0.85–0.92 on volume of 3,238 shares. Market capitalization is $38.33M, with a 52-week range of USD 0.74–2.58 (NCM). Source: Nexqual, July 25, 2026 at 15:00 UTC.
Key Statistics (as of July 25, 2026 at 15:00 UTC)
| Price | USD 0.89 |
|---|---|
| Change | ▼ 0.05% (down) |
| Previous Close | USD 0.89 |
| Open | USD 0.89 |
| Day Range | USD 0.85 – 0.92 |
| 52-Week Range | USD 0.74 – 2.58 |
| Volume | 3,238 shares |
| Market Cap | $38.33M |
| Exchange | NCM |
Technical Analysis (AACG)
Nexqual's technical model rates AACG "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 15:00 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 36.26 (neutral) |
| vs SMA50 | Below (USD 1.05) |
| MACD | -0.04 (negative) |
Analyst Ratings (AACG)
Wall Street analysts rate AACG "None", per Nexqual as of July 25, 2026 at 15:00 UTC.
| Consensus Rating | None |
|---|
Earnings (AACG)
Source: Nexqual, July 25, 2026 at 15:00 UTC.
Financials & Fundamentals (AACG)
| Total Revenue | $527.01M |
|---|---|
| Revenue Growth (YoY) | -11.70% |
| Gross Margin | +46.87% |
| Operating Margin | +12.22% |
| Profit Margin | -4.57% |
| ROE | -6.18% |
| Debt / Equity | 143.68 |
| Current Ratio | 2.59 |
| Total Cash | $85.24M |
| Total Debt | $45.95M |
Source: Nexqual, July 25, 2026 at 15:00 UTC.
Financial Health Score (AACG)
Nexqual rates AACG's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 15:00 UTC.
| Growth | Critical — Revenue -100% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $85M cash vs $46M debt, net cash position |
| Cash Flow | Mixed — No data |
| Efficiency | Critical — ROE -6%, ROA 5.0% |
Ownership (AACG)
| Insider Ownership | +3.45% |
|---|---|
| Institutional Ownership | +7.42% |
| Shares Outstanding | 43.21M |
| Float | 5.98M |
| Short % of Float | +0.06% |
Source: Nexqual, July 25, 2026 at 15:00 UTC.
Leadership (AACG)
AACG is led by Xiaofeng Ma (age 61), Co-Founder, Chairman & CEO, per Nexqual as of July 25, 2026 at 15:00 UTC.
| Co-Founder, Chairman & CEO | Xiaofeng Ma (age 61) |
|---|---|
| CFO & Director | Ruobai Sima (age 43) |
Major Backers & Investors (AACG)
Notable institutional backers of AACG include Renaissance Technologies, Citadel, according to Nexqual as of July 25, 2026 at 15:00 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Renaissance Technologies | 0.14% |
| Citadel | 0.14% |
Source: Nexqual, July 25, 2026 at 15:00 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CMPS | COMPASS Pathways Plc - American | USD 11.26 | ▼ 5.62% |
| HELP | Cybin Inc. | USD 7.62 | ▼ 2.56% |
| DFTX | Definium Therapeutics, Inc. | USD 43.17 | ▼ 1.14% |
| AAME | Atlantic American Corporation | USD 1.57 | ▼ 0.63% |
| NCTY | The9 Limited - American Deposit | USD 3.21 | ▼ 18.94% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 15:00 UTC. This page is informational and not investment advice.